Stay updated on Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page footer revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check14 days agoChange DetectedThe location entry 'Padua, Italy, 35128' was updated to 'Padova, Italy, 35128' in the study locations.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedReplaced Napoli, Italy, 80131 with Naples, Italy, 80131 in the study locations.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check64 days agoChange DetectedStudy status updated to Completed with new completion/actual dates; the previous Active, not recruiting status was removed.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.4.2 was added and the government funding lapse notice was removed from the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.